Accenture plc ACN has joined AI4BetterHearts, a global data collaborative that uses artificial intelligence and advanced analytics to pool, mine and analyze heart health data to help patients, health workers, health system managers and policymakers improve decision making on heart health.
Accenture said that its goal behind joining the collaborative is to support and advance cardiovascular disease prevention through integrating innovation and emerging technologies.
Stuart Henderson, global Life Sciences lead for Accenture, noted, "By applying technology, we can develop data-driven insights on the true catalysts of health and equity and help drive informed decisions for policy change."
AI4BetterHearts was founded by Microsoft MSFT and the Novartis NVS Foundation, and is the first global data collaborative for improving cardiovascular health.
Microsoft focuses on enhancing data sharing and cross-border research collaboration using its Microsoft AI for Health initiative, Open Data Campaign and its focused AI work.
Novartis contributes data from its urban health initiative, Better Hearts Better Cities, in Latin America, Africa and Asia, and from other programs as well.
Zacks Rank and Price Performance
Accenture currently carries Zacks Rank #3 (Hold). Its shares have gained 21.2% over the past year, underperforming the 23.1% growth of the industry.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Accenture PLC Price
Accenture PLC price | Accenture PLC Quote
Microsoft also carries a Zacks Rank #3. The stock appreciated 24.3% over the past year, outperforming the 13.4% growth of the industry it belongs to.
Novartis carries a Zacks Rank #4 (Sell). Its shares have gained 0.5% over the past year compared with 26.7% growth of the industry.
Just Released: Zacks Top 10 Stocks for 2022
In addition to the investment ideas discussed above, would you like to know about our 10 top buy-and-hold tickers for the entirety of 2022?
Last year's 2021 Zacks Top 10 Stocks portfolio returned gains as high as +147.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys
Access Zacks Top 10 Stocks for 2022 today >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Novartis AG (NVS): Free Stock Analysis Report
Microsoft Corporation (MSFT): Free Stock Analysis Report
Accenture PLC (ACN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
